Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jun 1;121(3):595-9.
doi: 10.1016/j.ygyno.2011.02.005. Epub 2011 Mar 12.

Effect of age and comorbidity on the treatment and survival of older patients with vulvar cancer

Rahel G Ghebre  1 , Rebecca Posthuma, Rachel Isaksson Vogel, Melissa A Geller, Linda F Carson
Affiliations

Effect of age and comorbidity on the treatment and survival of older patients with vulvar cancer

Rahel G Ghebre et al. Gynecol Oncol. .

Abstract

Objective: To determine the disease characteristics and comorbidities predictive of vulvar cancer specific mortality and five year overall survival among older women, ages 65 and above.

Methods: A retrospective analysis was conducted of women diagnosed with vulvar cancer at a single regional cancer center from 1989 to 2003, with a follow up to 2009. Treatment records were extracted for: demographics and treatment information, Eastern Cooperative Oncology Group (ECOG) performance status and Charlson comorbidity index score. Probability of death from vulvar cancer was estimated using cumulative incidence, treating death by other known and unknown causes as competing risks. Predictors of overall survival were determined using multivariate Cox regression analyses.

Results: One hundred forty-six women were identified, with a median age at diagnosis of 79 years (range 65-95). Median follow up was 5.0 years (range 0.1-16.7 years). The cumulative incidence of vulvar cancer-specific mortality was 13% (95% CI: 0.08-0.19) at year one, 24% (95% CI: 0.17-0.31) at year three and 26% (95% CI: 0.19-0.33) at year five. Use of adjuvant therapy or surgical procedure performed did not differ by age at diagnosis (p=0.807 and 0.663) according to age group (65-74, 74-84 and 85+). Increasing age, Charlson comorbidity index score, lymph node involvement and type of surgery performed were associated with increased risk of death from any cause (all p<0.05).

Conclusion: Among women aged ≥65, vulvar cancer specific mortality was most significant in the first three years after diagnosis. Conversely other causes of mortality which can be attributed to comorbid conditions steadily increased with time.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Cumulative incidence of death by cause: vulvar cancer or other known cause.
Fig. 2
Fig. 2
The cumulative incidence of death from vulvar cancer or other known causes by age at diagnosis. (A) Vulvar cancer specific mortality by age of diagnosis. (B) Other cause specific mortality by age of diagnosis.
See this image and copyright information in PMC

References

    1. Saraiya M, Watson M, Wu X, King JB, Chen VW, Smith JS, et al. Incidence of in situ and invasive vulvar cancer in the US, 1998–2003. Cancer. 2008;113:2865–72. - PubMed
    1. Judson PL, Habermann EB, Baxter NN, Durham SB, Virnig BA. Trends in the incidence of invasive and in situ vulvar carcinoma. Obstet Gynecol. 2006;107:1018–22. - PubMed
    1. Arias E. National vital statistics reports. 21. Vol. 58. National Center for Health Statistics; Hyattsville, MD: 2010. United States life tables, 2006. - PubMed
    1. Homesley HD, Bundy BN, Sedlis A, Yordan E, Berek JS, Jahshan A, et al. Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (a Gynecologic Oncology Group study) Am J Obstet Gynecol. 1991;164:997–1003. - PubMed
    1. Landrum LM, Lanneau GS, Skaggs VJ, Gould N, Walker JL, McMeekin DS, et al. Gynecologic Oncology Group risk groups for vulvar carcinoma: improvement in survival in the modern era. Gynecol Oncol. 2007;106:521–5. - PubMed

Publication types